Trial intelligence / Profile preview

Disulfiram for Cocaine Abuse in Buprenorphine Treatment

NCT00913484Phase 2Completed

Sponsor
Yale University
Start
Oct 2000
Primary completion
Feb 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in cocaine dependence comparing Disulfiram with Placebo (2 arms). Primary endpoint: Cocaine abstinence at 12 weeks. Started Oct 2000; status: completed.

02

Drugs

disulfiram
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT00913484.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00913484.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call